Jianmin Hu

Jianmin Hu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
LHLuoming Huang
Luoming Huang
XCXuelan Chen
Xuelan Chen
JLJiajia Lin
Jiajia Lin
XFXianming Fan
Xianming Fan
TCTing Chen
Ting Chen
JHJianmin Hu
Jianmin Hu
Background: The studies on the association between sleep duration and myopia are limited, and the evidence is inconsistent. This study aimed to evaluate the association between sleep duration and myopia, cycloplegic spherical equivalent (SE) and axial length (AL) among Chinese children during the Corona Virus Disease 2019 (COVID-19) pandemic.Methods: The study was a cross-sectional study on Chinese children aged 6–18 years. The comprehensive ophthalmic examinations for children included cycloplegic SE, AL, and standardized questionnaires. The questionnaire included sleep duration, parental myopia, outdoor time, and continuous near work duration without breaks. Myopia was defined as SE ≤-0.50 diopters (D).Results: A total of 1,140 children were included in the analyses, with 84.7% of myopic children and 74.4% of children's daily sleep duration being more than 8 h/d. In univariate regression analysis, compared with sleep duration < 8 h/d, children with sleep duration of 8–9 and >9 h/d were less myopia (p < 0.01 for all), and had less myopic SE (p < 0.01 for all), and shorter AL (p < 0.01 for all). After adjusting for age, gender, parental myopia, outdoor time, and continuous near work duration without breaks, sleep duration was not associated with myopia, cycloplegic SE, and AL (p > 0.05 for all).Conclusions: This study showed sleep duration was related to myopia, cycloplegic SE, and AL among Chinese children during the COVID-19 pandemic-related lifestyles, but no independent association.

21 October 2023 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
LLLicheng Li
Licheng Li
YYYang Yu
Yang Yu
ZZZihao Zhuang
Zihao Zhuang
QWQi Wu
Qi Wu
SLShu Lin
Shu Lin
JHJianmin Hu
Jianmin Hu

1 June 2020 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
BDBingfa Dai
Bingfa Dai
YYYang Yu
Yang Yu
LHLijuan Huang
Lijuan Huang
ZMZhiyong Meng
Zhiyong Meng
LCLiang Chen
Liang Chen
JHJianmin Hu
Jianmin Hu
Background: To explore the application of neural network models in artificial intelligence (AI)-aided devices fitting for low vision patients. Methods: The data of 836 visually impaired people were collected in southwestern Fujian from May 2014 to May 2017. After a full eye examination, 629 low vision patients were selected from this group. Based on the visual functions, rehabilitation needs, and living quality scores of the selected patients, the professionals chose assistive devices that were the best fit for the patients. The data of these three factors were then subjected to the quantitative analysis, and the results were digitized and labeled. The final datasets were used to train a fully connected deep neural networks to obtain an AI-aided model for assistive device fitting. Results: In this study, the main causes of low vision in southwestern Fujian were congenital diseases, among which congenital cataract was the most common. During the low vision AI-aided devices fitting, we found that the intermediate distance magnifier was suitable for the largest number of patients. Through quantitative analysis of the research results, it was found that AI-aided devices fitting was closely related to visual function, rehabilitation needs and quality of life. If this complex relationship can be mapped into the neural network model, AI-aided device fitting can be realized. We built a fully connected neural network model for AI-aided device fitting. The input of the model was the characteristic data of low vision patients, and the output was the forecast of suitable devices. When the threshold of the model was 0.4, the accuracy was about 80% and the F1 value was about 0.31. This threshold can be used as the classification judgment threshold of the model. Conclusions: Low vision AI-aided device fitting is closely related to visual function, rehabilitation needs, and quality of life scores. The neural network model based on full connection can achieve high accuracy in AI-aided devices fitting. It has a great impact on clinical application.

18 May 2023 in International Journal of Ophthalmology
Verified
Journal Article
Closed access
LHLuo-Ming Huang
Luo-Ming Huang
XFXian-Ming Fan
Xian-Ming Fan
YXYu-Hong Xie
Yu-Hong Xie
ZMZhi-Yong Meng
Zhi-Yong Meng
TCTing Chen
Ting Chen
JHJianmin Hu
Jianmin Hu
AIM: To investigate the myopia awareness level, knowledge, attitude, and skills at baseline and to implement and evaluate the efficacy of myopia prevention health education among Chinese students. METHODS: A total of 1000 middle school students from 2 middle schools were invited to participate in the study, and myopia prevention health education was conducted. The students were assessed at baseline, followed by a survey. The efficacy of health education was evaluated using the self-comparison method pre- and post-health education. RESULTS: The study included 957 and 850 pre- and post-health education participants, respectively. The baseline knowledge of all respondents on myopic symptoms (87.5%), myopia is a risk of eyes (72.9%), myopia prevention (91.3%), myopia increases with age (86.7%), performing periodic eye examinations (92.8%), and one first, one foot, and one inch (84.8%) significantly increased after health education (P<0.001 for all). However, the percentage of students who still did not think it necessary to take breaks after 30-40min of continuous near work was 27.0%. The opinion that “myopia can be cured” was still present in 38.3%. CONCLUSION: Implementing school-based myopia prevention health education improves knowledge, attitudes, and skills regarding myopia among Chinese middle school students.

7 June 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
LLLicheng Li
Licheng Li
YYYang Yu
Yang Yu
SLShu Lin
Shu Lin
JHJianmin Hu
Jianmin Hu
Background: Stem cell transplantation may improve visual acuity in patients with dry age-related macular degeneration. Herein, we aimed to summarise the evidence on the risks and benefits of stem cell transplantation for improving visual acuity, including the risk of adverse events. Methods: Data were obtained from the PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials databases, and each database was interrogated from the date of inception until 19 March 2022. The rates of visual acuity outcomes and adverse events associated with stem cell transplantation were examined. All statistical analyses were conducted using Review Manager 5.4. The study was registered with PROSPERO (CRD 42022322902). Results: The analysis examined 10 studies (102 patients), including one and three, randomised and non-randomised clinical trials, and one and five, multicentre prospective and prospective clinical trials, respectively. Meta-analysis showed changes in best-corrected visual acuity in the study eyes after stem cell transplantation (6 months: risk ratio [RR] = 17.00, 95% confidence interval [CI] 6.08–47.56, P < 0.00001; 12 months: RR = 11.00, 95% CI 2.36–51.36, P = 0.002). Subgroup analysis showed that different stem cell types achieved better best-corrected visual acuity at post-operative 6 months, compared to that observed at baseline. Four cases of related ocular adverse events and no related systemic adverse events were reported. Conclusion: This meta-analysis suggests that stem cell transplantation may improve best-corrected visual acuity in dry age-related macular degeneration, based on small sample sizes and fewer randomised controlled trials.

10 January 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YYYang Yu
Yang Yu
LLLicheng Li
Licheng Li
SLShu Lin
Shu Lin
JHJianmin Hu
Jianmin Hu
Age-related macular degeneration, diabetic retinopathy, retinitis pigmentosa and other retinal disorders are the main causes of visual impairment worldwide. In the past, these retinal diseases, especially dry age-related macular degeneration, proliferative diabetic retinopathy and retinitis pigmentosa, were treated with traditional surgery and drugs. However, the effect was moderate. In recent years, researchers have used embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, olfactory ensheathing cells and other stem cells to conduct experiments and found that stem cells can inhibit inflammation, regulate immune response, secrete neurotrophic factors, and differentiate into retinal cells to replace and promote restoration of the damaged parts. These stem cells have the potential to treat retinal diseases. Whether it is in animal experiments or clinical trials, the increase in the number of retinal cells, maintenance of function and improvement of visual function all reflect the advanced of stem cells to treat retinal diseases, but its risk preserves the donor’s hidden pathogenic genes, immune rejection and tumorigenicity. With the development of exosomes study, researchers have discovered that exosomes come from a wide range of sources and can be secreted by almost all types of cells. Using exosomes with stem cell to treat retinal diseases is more effective than using stem cells alone. This review article summarizes the recent advances in the application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders.